Benjamin F. Edwards & Company, Inc. Coll Plant Biotechnologies LTD Transaction History

Benjamin F. Edwards & Company, Inc.

$5.51 Billion
Q1 2024

A detailed history of Benjamin F. Edwards & Company, Inc. transactions in Coll Plant Biotechnologies LTD stock. As of the latest transaction made, Benjamin F. Edwards & Company, Inc. holds 50,450 shares of CLGN stock, worth $250,232. This represents 0.0% of its overall portfolio holdings.

Number of Shares

50,450

Previous 50,150 0.6%

Holding current value

$250,232

Previous $320,000 15.0%

% of portfolio

0.0%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	BUY	$4.72 - $6.15 $1,416 - $1,845	300 Added 0.6%	50,450 $272,000
Q4 2023 Feb 06, 2024	BUY	$4.97 - $6.64 $25,347 - $33,864	5,100 Added 11.32%	50,150 $320,000
Q3 2023 Nov 13, 2023	SELL	$5.4 - $8.05 $22,464 - $33,488	-4,160 Reduced 8.45%	45,050 $254,000
Q2 2023 Aug 15, 2023	SELL	$6.6 - $8.23 $110,226 - $137,449	-16,701 Reduced 25.34%	49,210 $399,000
Q1 2023 Apr 27, 2023	BUY	$6.74 - $12.99 $32,763 - $63,144	4,861 Added 7.96%	65,911 $463,000

Q4 2022 Feb 07, 2023	SELL	$4.71 - $9.5 $20,535 - $41,420	-4,360 Reduced 6.67%	61,050 $510,000
Q3 2022 Oct 28, 2022	SELL	$6.87 - $9.99 $43,968 - $63,936	-6,400 Reduced 8.91%	65,410 $447,000
Q2 2022 Aug 12, 2022	SELL	$8.0 - $11.19 $27,680 - $38,717	-3,460 Reduced 4.6%	71,810 $585,000
Q1 2022 May 04, 2022	BUY	$8.97 - $16.4 $148,686 - $271,846	16,576 Added 28.24%	75,270 $861,000
Q4 2021 Feb 07, 2022	BUY	$12.0 - $22.48 $12,600 - $23,604	1,050 Added 1.82%	58,694 $960,000
Q3 2021 Nov 02, 2021	SELL	$16.0 - $21.75 $111,840 - $152,032	-6,990 Reduced 10.81%	57,644 $973,000
Q2 2021 Aug 11, 2021	BUY	$13.55 - $22.45 $875,790 - $1.45 Million	64,634 New	64,634 $1.37 Million

Others Institutions Holding CLGN

# of Institutions

Shares Held

1.88M

Call Options Held

200

Put Options Held

500

View Full List

About CollPlant Biotechnologies Ltd

Ticker CLGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,086,500
Market Cap $55M
Description
CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering tech...

More about CLGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Benjamin F. Edwards & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Benjamin F. Edwards & Company, Inc. with notifications on news.

Account

Benjamin F. Edwards & Company, Inc. Coll Plant Biotechnologies LTD Transaction History